Spursex
Alert Team
The new Covid variants and mutations: what we know about them
Tom Whipple
Friday January 15 2021, 12.01am, The Times
The Kent variant
During the lockdown in England in November, public health officials noted a strange anomaly. By the middle of the month in every region of the country the number of cases was falling or flat. Except, that is, in one part of Kent. Here, apparently unperturbed by the restrictions, it kept on rising. Were people ignoring the rules? Were they behaving differently? Scientists could find no explanation. In December they sent in the geneticists — and they spotted that one variant was proliferating. This variant had become a pandemic within a pandemic.
Key mutation N501Y
The spike protein is what the virus uses to enter cells, and it is on its tip that this single mutation seems to have given B.1.17, as the Kent variant is known, its edge. This cannot be the whole story. This single mutation will have happened many times as the virus reproduced, yet not taken off. It must be something about its interplay with other, less well-understood, mutations that enabled its sudden rise to supremacy.
The South Africa variant
South Africa did quite well in its first wave, peaking briefly at 300 deaths a day. By November cases were down to a little over 1,500, with 720,000 recorded through the whole pandemic. Then they rocketed. By December there were 800,000 cases. Two weeks later there were 900,000. Nine days after that, there were 1,000,000. Today there are 300,000 more. It took a while to identify a reason why. South Africa has less genetic surveillance than the UK. When they did look, they found their dominant variant also had the telltale N501Y mutation — which it had developed independently.
Key mutations
As well as N501Y, this variant has another mutation on the part of the spike that binds to cells, called E484K. John Bell, regius professor of medicine at Oxford, said this worried him. “If you get an immune response that protects you, one of the ways it protects you is it gets in the way of that binding event. You rely on antibodies to bind to that domain to stop the virus entering your cells.” If it changes, that means immunity might not be so high. “If you mess around with that you’re in trouble,” he said.
The Brazilian variant
In Manaus in April gravediggers had to work at night. Funeral homes ran out of coffins. Bodies were buried in trenches. In spring, this city of 2.2 million people let coronavirus rip. While the world was locking down, here the virus was left unchecked. They suffered for it, but they had every reason to hope that the worst was over. Many scientists thought that they had in fact reached that long-fabled state: herd immunity.
But, now, the hospitals are full once again. There are reports, equally worryingly, of reinfections. Here, too, a new variant has emerged — and once again there is evidence it has evolved to transmit more efficiently.
Key mutations
Like the South African variant, the Brazilian version also has the N501Y and E484K mutations. Experiments are under way to see what effect this has on immunity. It is possible that the E484K mutation will be able to evade some of our defences.
But most scientists think that while it might render vaccines or immunity less effective, it will not make them useless. And now we have the vaccines, they can be tweaked quickly to keep up.
Tom Whipple
Friday January 15 2021, 12.01am, The Times
The Kent variant
During the lockdown in England in November, public health officials noted a strange anomaly. By the middle of the month in every region of the country the number of cases was falling or flat. Except, that is, in one part of Kent. Here, apparently unperturbed by the restrictions, it kept on rising. Were people ignoring the rules? Were they behaving differently? Scientists could find no explanation. In December they sent in the geneticists — and they spotted that one variant was proliferating. This variant had become a pandemic within a pandemic.
Key mutation N501Y
The spike protein is what the virus uses to enter cells, and it is on its tip that this single mutation seems to have given B.1.17, as the Kent variant is known, its edge. This cannot be the whole story. This single mutation will have happened many times as the virus reproduced, yet not taken off. It must be something about its interplay with other, less well-understood, mutations that enabled its sudden rise to supremacy.
The South Africa variant
South Africa did quite well in its first wave, peaking briefly at 300 deaths a day. By November cases were down to a little over 1,500, with 720,000 recorded through the whole pandemic. Then they rocketed. By December there were 800,000 cases. Two weeks later there were 900,000. Nine days after that, there were 1,000,000. Today there are 300,000 more. It took a while to identify a reason why. South Africa has less genetic surveillance than the UK. When they did look, they found their dominant variant also had the telltale N501Y mutation — which it had developed independently.
Key mutations
As well as N501Y, this variant has another mutation on the part of the spike that binds to cells, called E484K. John Bell, regius professor of medicine at Oxford, said this worried him. “If you get an immune response that protects you, one of the ways it protects you is it gets in the way of that binding event. You rely on antibodies to bind to that domain to stop the virus entering your cells.” If it changes, that means immunity might not be so high. “If you mess around with that you’re in trouble,” he said.
The Brazilian variant
In Manaus in April gravediggers had to work at night. Funeral homes ran out of coffins. Bodies were buried in trenches. In spring, this city of 2.2 million people let coronavirus rip. While the world was locking down, here the virus was left unchecked. They suffered for it, but they had every reason to hope that the worst was over. Many scientists thought that they had in fact reached that long-fabled state: herd immunity.
But, now, the hospitals are full once again. There are reports, equally worryingly, of reinfections. Here, too, a new variant has emerged — and once again there is evidence it has evolved to transmit more efficiently.
Key mutations
Like the South African variant, the Brazilian version also has the N501Y and E484K mutations. Experiments are under way to see what effect this has on immunity. It is possible that the E484K mutation will be able to evade some of our defences.
But most scientists think that while it might render vaccines or immunity less effective, it will not make them useless. And now we have the vaccines, they can be tweaked quickly to keep up.